The effect of clinical decision making for initiation of systemic anticancer treatments in response to the COVID-19 pandemic in England: a retrospective analysis
Cancer services worldwide had to adapt in response to the COVID-19 pandemic to minimize risk to patients and staff. We aimed to assess the national impact of the pandemic on the prescribing of anticancer treatment in England. After the onset of the COVID-19 pandemic, there was a reduction in anticancer treatment initiation in England.
